Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients
Conditions: Genetic Polymorphisms; Heart Failure Interventions: Drug: SGLT2 inhibitors (Dapagliflozin and Empagliflozin) Sponsors: October 6 University; University of Florida; National Heart Institute, Egypt; Beni-Suef University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Cardiac Amyloidosis in HFpEF Tunisian Patients
Conditions: Cardiac Amyloidosis; Heart Failure With Preserved Ejection Fraction; Echocardiography; CMR; Bone Scintigraphy; TTR Cardiac Amyloidosis; AL Amyloidosis; Prevalence; Diagnosis Sponsors: University Tunis El Manar Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Edge AI-deployed DIGItal Twins for PREDICTing Disease Progression and Need for Early Intervention in Infectious and Cardiovascular Diseases Beyond COVID-19 - Investigation of Biomarkers in Dermal Interstitial Fluid
Conditions: Heart Failure Interventions: Device: Use of the PELSA System for dISF extraction Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
Conditions: Heart Failure; Systemic Inflammation Interventions: Drug: Ziltivekimab; Drug: Placebo Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Cardio-vascular Energy Transfer and Ventriculo-arterial Coupling in Heart Failure
Conditions: Heart Failure, Left-sided Sponsors: St. Olavs Hospital; National Taiwan Normal University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure
Conditions: Heart Failure; Aortic Stenosis, Severe Interventions: Drug: Levosimontane injection Sponsors: Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Myocardial Stiffness Evaluation in Patients With Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure With Preserved Ejection Fraction Interventions: Diagnostic Test: Echocardiography examination Sponsors: Haiyan Wang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Contrast Echocardiography During Exercise to Assess Pulmonary Blood Volume
Conditions: Heart Failure; Pulmonary Vascular Disease Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Ketones in Heart Failure With Reduced Ejection Fraction
Conditions: Heart Failure With Reduced Ejection Fraction Interventions: Dietary Supplement: ketone ester; Dietary Supplement: placebo Sponsors: Duke University; American Heart Association; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction
Conditions: Chronic Heart Failure With Reduced Ejection Fraction Interventions: Drug: Vericiguat (BAY1021189) 5 mg Sponsors: Bayer; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study
Conditions: Congestive Heart Failure Interventions: Device: Baroreflex Activation Therapy (BAT) Sponsors: Brian Houston; CVRx, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry
Conditions: Heart Failure Sponsors: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia; Fondazione C.N.R./Regione Toscana " G. Monasterio " , Pisa, Italy; Centro Cardiologico Monzino; A.O. Ospedale Papa Giovanni XXIII; IRCCS Ospedale San Raffaele; Azienda Ospedaliera Universitaria Senese; IRCCS Humanitas, Rozzano; Ospedale Policlinico San Martino; Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico; Fondazione IRCCS Policlinico San Matteo di Pavia; Ospedali Riuniti di Foggia; Azienda Ospedaliera Citt à della Salute e della Scienza di Torino; ASU Giuliano Isontina, Trieste; Azienda Ospedaliera S. ...
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction
Conditions: Myocardial Infarction; Heart Failure Interventions: Drug: Henagliflozin Sponsors: Qian geng Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece
Conditions: Hyperkalaemia Interventions: Drug: sodium zirconium cyclosilicate (SZC) Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
A Pilot Randomized Trial of Hybrid Persistent Atrial Fibrillation Ablation in Heart Failure
Conditions: Atrial Fibrillation; Heart Failure Interventions: Procedure: Convergent ablation; Procedure: Catheter ablation Sponsors: The Cleveland Clinic; AtriCure, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
